A study in prostate cancer patients integrated cfDNA fragment information with WGS data122: one patient exhibited a clonal switch in dominant population at the time of androgen inhibitor resistance where parallel fragment-based inferred gene expression analysis at androgen receptor binding sites demonstrated commensurate loss of downstream androgen receptor signaling. Here, AR is linked to prostate carcinoma.